Michael Hahne

Inhibition of death receptor signals by cellular FLIP

Martin Irmler, Margot Thome, Michael Hahne et al. · Nature · 1997 · 2.6K citations · Full text

Life Sciences, Cell Biology, Oncology +14

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations

Life Sciences, Immunology, Oncology +17

Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity

Pascal Schneider, Nils Holler, Jean-Luc Bodmer et al. · The Journal of Experimental Medicine · 1998 · 803 citations · Full text

Life Sciences, Cell Biology, Immunology +16

The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways

Takao Kataoka, Ralph C. Budd, Nils Holler et al. · Current Biology · 2000 · 552 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

Michael Hahne, Takao Kataoka, Michael Schröter et al. · The Journal of Experimental Medicine · 1998 · 506 citations · Full text

Medicine, Cancer Biology, Oncology +11